Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class III · Low risk

Minocycline Hydrochloride Capsules USP

Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.

Terminated Labeling / mix-up Apace KY LLC NDC 50268-569-11 D-0811-2016
Class I · High risk

Morphine Sulfate 0.5 mg/mL

Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.

Terminated Wrong potency / content Pharmakon Pharmaceuticals NDC 45183-0322-78 D-0871-2016
Class II · Moderate risk

Alendronate Sodium Tablets

Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.

Terminated Impurity / degradation Sun Pharma Global Fze NDC 41616-638-68 D-0735-2016
Class II · Moderate risk

TEARS Naturale FREE

Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.

Terminated Sterility / contamination Alcon Research, Ltd. D-0666-2016

Recalls by year